Dimensional Fund Advisors’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Dimensional Fund Advisors’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-132,385	Closed	-$271K	–	3550
2022 Q1	$271K	Buy	132,385 +67,762	+105%	+$161K	﹤0.01%	3266
2021 Q4	$186K	Hold	64,623	–	–	﹤0.01%	3355
2021 Q3	$274K	Buy	64,623 +11,311	+21%	+$50.5K	﹤0.01%	3294
2021 Q2	$282K	Sell	53,312 -1,554	-3%	-$7.47K	﹤0.01%	3271
2021 Q1	$255K	Hold	54,866	–	–	﹤0.01%	3248
2020 Q4	$181K	Hold	54,866	–	–	﹤0.01%	3234
2020 Q3	$182K	Hold	54,866	–	–	﹤0.01%	3211
2020 Q2	$185K	Sell	54,866 -8,462	-13%	-$40K	﹤0.01%	3217
2020 Q1	$243K	Buy	63,328 +8,462	+15%	+$39.3K	﹤0.01%	3179
2019 Q4	$331K	Sell	54,866 -1,077	-2%	-$7.37K	﹤0.01%	3195
2019 Q3	$423K	Hold	55,943	–	–	﹤0.01%	3172
2019 Q2	$758K	Hold	55,943	–	–	﹤0.01%	3112
2019 Q1	$303K	Hold	55,943	–	–	﹤0.01%	3255
2018 Q4	$166K	Sell	55,943 -6,727	-11%	-$36.8K	﹤0.01%	3307
2018 Q3	$511K	Hold	62,670	–	–	﹤0.01%	3178
2018 Q2	$610K	Buy	62,670 +6,195	+11%	+$63.5K	﹤0.01%	3094
2018 Q1	$491K	Hold	56,475	–	–	﹤0.01%	3113
2017 Q4	$707K	Buy	+56,475	New	+$647K	﹤0.01%	3048

Other funds holding ZYNE

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

IEFM

IQ EQ Fund Management Dublin 2, Ireland $1.32B AUM 31.52% 1-Year Est. Return

Dimensional Fund Advisors's ZYNE Position: Q2 2022 in Review

Dimensional Fund Advisors sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q2 2022, closing a stake of 132,385 shares — an estimated $271K sold.

Dimensional Fund Advisors first reported a position in ZYNE in Q4 2017 and held it in 18 quarters. The position peaked at $758K in Q2 2019. 56 funds tracked by Wall St. Rank hold ZYNE as of Q2 2022.

Dimensional Fund Advisors reported no remaining Zynerba Pharmaceuticals, Inc position as of Q2 2022 after selling out during the quarter.
Dimensional Fund Advisors sold 132,385 Zynerba Pharmaceuticals, Inc shares in Q2 2022, an estimated $271K.
Dimensional Fund Advisors first reported a position in Zynerba Pharmaceuticals, Inc in Q4 2017 and held it in 18 quarters.
Dimensional Fund Advisors's Zynerba Pharmaceuticals, Inc position peaked at $758K in Q2 2019.
56 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q2 2022.

Based on Dimensional Fund Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.